Insider Transactions in Q1 2021 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
25,000
-4.51%
|
$1,550,000
$62.2 P/Share
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,017
-1.43%
|
$601,020
$60.93 P/Share
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Other acquisition or disposition
|
Direct |
2,854
+0.49%
|
-
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,302
+2.8%
|
-
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Other acquisition or disposition
|
Direct |
167
-0.13%
|
-
|
|
Mar 10
2021
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
3,505
-4.43%
|
$210,300
$60.93 P/Share
|
|
Mar 10
2021
|
Rupert Vessey EVP & President, Research |
BUY
Other acquisition or disposition
|
Direct |
139
+0.18%
|
-
|
|
Mar 10
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
7,423
+8.58%
|
-
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Payment of exercise price or tax liability
|
Direct |
14,589
-6.66%
|
$875,340
$60.93 P/Share
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Other acquisition or disposition
|
Direct |
3,450
+1.77%
|
-
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Exercise of conversion of derivative security
|
Direct |
31,575
+12.55%
|
-
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Other acquisition or disposition
|
Direct |
257
-0.81%
|
-
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,662
-4.23%
|
$159,720
$60.93 P/Share
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
BUY
Other acquisition or disposition
|
Direct |
1,045
+1.83%
|
-
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
7,483
+10.6%
|
-
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
SELL
Other acquisition or disposition
|
Direct |
60
-0.66%
|
-
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
14,329
-4.16%
|
$859,740
$60.93 P/Share
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
BUY
Other acquisition or disposition
|
Direct |
4,179
+1.38%
|
-
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
29,835
+7.9%
|
-
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
SELL
Other acquisition or disposition
|
Direct |
244
-0.43%
|
-
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
31,200
-1.67%
|
$1,872,000
$60.93 P/Share
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
BUY
Other acquisition or disposition
|
Direct |
5,554
+0.36%
|
-
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
50,373
+2.6%
|
-
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
SELL
Other acquisition or disposition
|
Direct |
413
-0.12%
|
-
|
|
Mar 10
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,978
-21.59%
|
$118,680
$60.93 P/Share
|
|
Mar 10
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Other acquisition or disposition
|
Direct |
78
+0.84%
|
-
|
|
Mar 10
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,189
+31.57%
|
-
|
|
Mar 10
2021
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,329
-4.74%
|
$259,740
$60.93 P/Share
|
|
Mar 10
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
150
+0.16%
|
-
|
|
Mar 10
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,025
+8.09%
|
-
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
2,192
-6.72%
|
$131,520
$60.93 P/Share
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Other acquisition or disposition
|
Direct |
909
+3.13%
|
-
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
6,134
+16.03%
|
-
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Other acquisition or disposition
|
Direct |
55
-1.1%
|
-
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,910
-2.08%
|
$114,600
$60.93 P/Share
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Other acquisition or disposition
|
Direct |
718
+0.93%
|
-
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,404
+5.55%
|
-
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Other acquisition or disposition
|
Direct |
36
-0.23%
|
-
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,851
-7.47%
|
$771,060
$60.93 P/Share
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
2,643
+1.78%
|
-
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,215
+12.77%
|
-
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
154
-0.61%
|
-
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
112,233
-4.04%
|
$6,733,980
$60.93 P/Share
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
BUY
Other acquisition or disposition
|
Direct |
22,035
+0.94%
|
-
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
200,709
+6.63%
|
-
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Other acquisition or disposition
|
Direct |
1,635
-0.34%
|
-
|
|
Mar 01
2021
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
8,944
-11.1%
|
$545,584
$61.63 P/Share
|
|
Mar 01
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
23,349
+22.47%
|
-
|
|
Mar 01
2021
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,573
-9.34%
|
$522,953
$61.63 P/Share
|
|
Mar 01
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,579
+21.13%
|
-
|